US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: Navigating a 23.83% Potential Upside in the Medical Device Sector

Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity for investors in the dynamic healthcare sector. As a leading player in the medical devices industry, Haemonetics offers a diverse range of..

Amicus Therapeutics, Inc. (FOLD) Investor Outlook: Uncovering a 158% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) presents a captivating opportunity for investors, particularly those interested in the healthcare sector and the biotechnology industry. Headquartered in Princeton, New Jersey, this company specializes..

Premier, Inc. (PINC) Stock Analysis: Navigating the Healthcare Services Landscape with a 4% Dividend Yield

Premier, Inc. (NASDAQ: PINC) is a notable player in the healthcare information services sector, commanding a market capitalization of approximately $1.93 billion. As a healthcare improvement company based in the..

MoonLake Immunotherapeutics (MLTX): Analyst Consensus Reveals Significant 43.76% Potential Upside

MoonLake Immunotherapeutics (MLTX), a clinical-stage biotechnology company based in Switzerland, is capturing investor attention with its promising therapeutic developments in the field of inflammatory diseases. With a market capitalization of..

Edgewise Therapeutics (EWTX): Unpacking a Potential 172% Stock Upside with Strong Analyst Confidence

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising contender in the biotechnology sector, is drawing investor attention with a potential upside of 172.22%, according to analyst consensus. This biopharmaceutical company, headquartered..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Exploring a 122% Upside Potential in Rare Disease Treatment

Travere Therapeutics, Inc. (TVTX) stands out in the biopharmaceutical landscape, focusing on developing therapies for rare kidney and metabolic diseases. With its headquarters in San Diego, California, the company has..

Organon & Co. (OGN) Stock Analysis: Evaluating a 33% Potential Upside Amidst Healthcare Sector Challenges

Investors considering Organon & Co. (NYSE: OGN) are looking at a company that, despite its challenges, offers intriguing prospects in the healthcare sector. With its roots dating back to 1923,..

Arcellx, Inc. (ACLX) Stock Analysis: Healthcare Innovator with a 57% Potential Upside

Arcellx, Inc. (NASDAQ: ACLX) has been capturing attention in the biotechnology sector with its innovative approach to immunotherapies targeting cancer and other incurable diseases. With a market capitalization of $3.89..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 80% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to the diagnostic testing solutions market. The..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 61.2% Potential Upside in Diagnostics and Research

Veracyte, Inc. (VCYT), a notable player in the healthcare sector, specifically in diagnostics and research, is garnering attention for its significant growth potential. Based in South San Francisco, California, Veracyte..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the 5.83% Potential Upside in Healthcare Diagnostics

GRAIL, Inc. (GRAL), a trailblazer in the healthcare diagnostics sector, is making waves with its innovative approach to multi-cancer early detection testing. The Menlo Park, California-based company, with a market..

Immunovant, Inc. (IMVT) Stock Analysis: A 148% Potential Upside in Biotech Investment

For investors seeking promising opportunities in the biotechnology sector, Immunovant, Inc. (NASDAQ: IMVT) presents an intriguing case with a remarkable potential upside of 148.04%. As a clinical-stage immunology company, Immunovant..

SS Innovations International (SSII) Stock Analysis: A Glimpse into the Future of Surgical Robotics with a 40.8% Revenue Growth

Investors with an eye on the burgeoning field of surgical robotics might find SS Innovations International, Inc. (SSII) an intriguing prospect. Based in Gurugram, India, SSII is carving a niche..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 6.81% Upside Potential

Brookdale Senior Living Inc. (NYSE: BKD) stands at the intersection of healthcare and real estate, offering senior living solutions across the United States. With a market capitalization of $1.76 billion,..

ICU Medical, Inc. (ICUI) Investor Outlook: Exploring a 46% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI) stands as a pivotal player in the healthcare sector, specializing in the production of medical devices for infusion therapy, vascular access, and vital care applications...

Alvotech (ALVO) Investor Outlook: Exploring a Potential 78.39% Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a healthcare innovator based in Luxembourg, is capturing investor attention with its robust pipeline of biosimilar products targeting significant therapeutic areas. Specializing in the development and manufacture..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Key Insights on an 84.68% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the medical devices industry with its innovative solutions for diabetes management. Based in San Diego, California, Tandem has carved a niche..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: A Biotech with Promising Revenue Growth Amidst Volatility

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), a burgeoning player in the biotechnology sector, is making waves with its innovative approach to treating rare diseases and cancer. Headquartered in Stamford, Connecticut, this..

Enovis Corporation (ENOV) Stock Analysis: Exploring a Potential 106% Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, is capturing investor attention with its promising potential for substantial returns. Operating primarily in the medical devices industry, Enovis..

Disc Medicine, Inc. (IRON) Investor Outlook: A Promising 63.50% Potential Upside in Biotech

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors, riding on the wave of its innovative approach to tackling serious hematologic diseases. With a $2.06 billion market cap,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds